This Week in BMC Cancer

Premium

This week in BMC Cancer, a team of US researchers reports that tetrathiomolybdate, a drug used to treat copper overload disorders, also sensitizes ovarian cancer cells to several anticancer drugs. The researchers explored the combination of TM with several reactive oxygen species-generating drugs like mitomycin C, fenretinide, 5-fluorouracil and doxorubicin in ovarian cancer cells.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.